Latest SpectraCure News & Updates

See the latest news and media coverage for SpectraCure. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
SpectraCure

Developer of photodynamic therapy systems for solid tumors

spectracure.com
Headquarters
Sweden
Founded year
2003
Company type
Public company
Number of employees
20–50

Last updated

Latest news about SpectraCure

In short: SpectraCure advanced its prostate cancer clinical trials and secured 15.6 MSEK through a warrant exercise, despite liquidity concerns from auditors.

Company announcements

  • SpectraCure

    SpectraCure publishes annual report for 2025

    The auditor questions the value of assets due to liquidity shortage, but the board assesses that financing can be secured. The annual report is available on the website.

  • SpectraCure

    SpectraCure calls for annual general meeting

    The meeting is held on 27 May 2026 in Lund. The nomination committee proposes board election, fees and share issue authorization. No dividend proposal.

  • SpectraCure

    SpectraCure publishes year-end report for 2025

    Reports financial results with loss after tax of -56 MSEK, leadership changes, clinical progress and regulatory approvals. Plans phase 3 studies.

  • SpectraCure

    SpectraCure AB decides on share issue in kind to guarantor

    The subscription period for TO5 expired on 28 January 2026. The board issues 4,667,168 shares at 0.10 SEK per share via set-off. Dilution effect approximately 0.8 percent.

Unlock all announcements with a

Media coverage

  • Nyheter24

    Spectracure applies for permission for clinical study of primary prostate cancer

    The research company Spectracure has decided to apply for permission to initiate a clinical study for primary localized prostate cancer. This appears from a press release.The board and management have during...

  • Life Science Sweden

    Spectracure receives EU grant to develop its treatment for prostate cancer

    With an EU grant of 125,000 euros, equivalent to 1.3 million Swedish kronor, Spectracure will adapt its system for the treatment of prostate cancer, in order to be able to mass-produce...

  • Reuters

    Spectracure FDA Has Approved Co's New Protocol For Clinical Trials

    China's Alibaba , said on Friday artificial intelligence was key to expanding its cloud computing business, as it reported strong quarterly growth in the sector...

  • Reuters

    SpectraCure Q4 Loss After Tax Widens To SEK 3.7 Mln

    China's consumer inflation slowed in December, leading to modest annual price gains for 2024 while factory-gate deflation extended into a second year, amid sputtering economic...

Unlock all articles with a

Never miss news about SpectraCure

Track SpectraCure and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

SpectraCure competitors & trending companies

Browse news for competitors to SpectraCure and other trending companies.